Personalised Health – From Genes to Society (pHealth) 2015-2021
pHealth examines changes in healthcare and investigates the individual and genetic causes of diseases as well as treatment-related issues. The research extends to societal issues that may arise with the collection and storage of health data.
The Academy Programme Personalised Health – From Genes to Society (pHealth) is centred on the concept of personalised medicine, a new, comprehensive line of health research that is changing healthcare all over the world. Personalised medicine involves a completely new approach to understanding, categorising, diagnosing, preventing and treating diseases and promoting good health. This approach is based on the definition of an individual’s genome, its function, cellular biochemistry and physiology, as well as on the utilisation of this information in individual medical treatment, disease prevention and nutritional profiling.
The first and foremost theme of the programme is to produce data and tools to contribute to the understanding of individual characteristics at molecular level, and to using these data and tools for health promotion.
Projects funded in the main call
Funding period: 2015-2019
Total funding: € 10 million
Projects
Personalized combination therapies for high-grade serous ovarian cancer patients (OVCURE)
- Sampsa Hautaniemi, University of Helsinki
- Olli Carpen, University of Turku
- Seija Grenman, University of Turku
- Tero Aittokallio, University of Helsinki
Good(s) for health: Personalized health services and flexible appropriation of bioinformation (GoHe)
- Ilpo Helén, University of Eastern Finland
- Hanna Lehtimäki, University of Eastern Finland
- Karoliina Snell, University of Helsinki
Action on Human Surfaces: Wound-Metagenomics (Bugsy)
- Liisa Holm, University of Helsinki
- Esko Kankuri, University of Helsinki
- Jyrki Vuola, The Hospital District of Helsinki and Uusimaa
- Pekka Varmanen, University of Helsinki
- Matti Kankainen, University of Helsinki
Dietary Gluten-induced Disease Entities - from genomics to personalized Health and Well-being (DIG IN Health)
- Katri Kaukinen, Tampere University
- Seppo Meri, University of Helsinki
- Päivi Saavalainen, University of Helsinki
Finnish cardiomyopathies - from genetics and phenotype to pathogenesis (CardioPath)
- Johanna Kuusisto, University of Eastern Finland
- Markku Laakso, University of Eastern Finland
- Jari Koistinaho, University of Eastern Finland
- Pasi-Petri Tavi, University of Eastern Finland
Personalised medicine to predict and prevent Type 1 Diabetes (P4 Diabetes)
- Riitta Lahesmaa, University of Turku
- Matej Oresic, University of Turku
- Mikael Knip, University of Helsinki
- Raimo Lahti, University of Helsinki
- Jorma Toppari, University of Turku
- Harri Lähdesmäki, Aalto University
Dyslexia: genes, brain functions, interventions (DYSGEBRA)
- Heikki Lyytinen, University of Jyväskylä
- Riitta Salmelin, Aalto University
- Juha Kere, Folkhälsan Institute of Genetics
Effects of ApoE4 genotype information and intervention intensity on the fulfillment of lifestyle changes and sensory preferences (ApoE4mot)
- Susanna Rokka, Natural Resources Institute Finland (Luke)
- Anu Hopia, University of Turku
- Kirsi Vähäkangas, University of Eastern Finland
Neurogenomics in routine diagnostics of children and adults: impact on patient care and cost-effectiveness (NEUROGENOMICS FINLAND)
- Henna Tyynismaa, Univeristy of Helsinki
- Tuula Lönnqvist, The Hospital District of Helsinki and Uusimaa
- Mari Auranen, The Hospital District of Helsinki and Uusimaa
- Mika Kortelainen, VATT Institute for Economic Research
- Anu Wartiovaara, University of Helsinki
European Research Collaboration ERAPerMed, JTC2018 Call ”Research Projects on Personalized Medicine – Smart Combination of Pre-Clinical and Clinical Research with Data and ITC Solutions”
Funding period 1 Jan 2019 – 31 Dec 2021, total funding € 1 200 000
Projects
Novel individualized therapies in JAK/STAT driven T-cell malignancies (JAKSTAT-TARGET)
- Satu Mustjoki, University of Helsinki
- Tero Aittokallio, University of Helsinki
Genomics-based tools for personalized treatment to reduce chemotherapy burden in pediatric cancer (GEPARD)
- Olli Lohi, University of Turku
- Merja Heinäniemi, University of Eastern Finland
Clinical implementation Of Multidimensional PhenotypicAl drug SenSitivities in paediatric precision oncology (COMPASS)
- Olli Kallioniemi, University of Helsinki
Rational antiepileptic drug selection by combining gene network and ICT analysis
- Reetta Kälviäinen, University of Eastern Finland
European Research Collaboration ERAPerMed, JTC2019 Call ”Personalized Medicine: Multidisciplinary Research Towards Implementation”
Funding period 1 Jan 2020 – 31 Dec 2022, total funding € 1 199 751
Projects
Metabolic vulnerabilities for personalized therapeutic approaches in acute myeloid leukemia (MEET-AML)
- Caroline Heckman, University of Helsinki
A novel tool for personalized and socio-economically optimal treatment planning for patients with osteoarthritis
- Rami Korhonen, University of Eastern Finland
- Simo Saarakkala, University of Oulu
Temporal disease map based stratification of depression-related multimorbidities: towards quantitative investigations of patient trajectories and predictions of multi-target drug candidates
- Mikko Kuokkanen, National Institute for Health and Welfare
Advancing Breast Cancer histopathology towards AI-based Personalised medicine
- Pekka Ruusuvuori, Tampere University
- Leena Latonen, University of Eastern Finland
Steering group of the pHealth academy Programme (until 31 Dec 2021):
- Mika Rämet, Research Council for Biosciences, Health and the Environment (chair)
- Maritta Välimäki, Research Council for Biosciences, Health and the Environment
- Tuire Kuusi, Research Council for Culture and Society
- Markus Perola, Research Council for Biosciences, Health and the Environment
- Minnamari Vippola, Research Council for Natural Sciences and Engineering
- Pirjo Nuutila, University of Turku
- Jorma Palvimo, University of Eastern Finland
- Liisa-Maria Voipio-Pulkki, Ministry of Social Affairs and Health
- Sampo Sammalisto, Business Finland
More information
- Questions about calls and grant management: helpdesk
Our email addresses are in the format firstname.lastname(at)aka.fi.
